Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check2 days agoChange DetectedThe study page no longer displays the 'Melanoma' disease label or the 'MedlinePlus Genetics' related topics link, altering the disease context and available related resources on the page.SummaryDifference0.2%

- Check9 days agoChange DetectedMelanoma is added as a related topic and MedlinePlus Genetics as a related topic in the study’s metadata. This expands the contextual keywords and helps link the trial to related resources without changing the trial's substantive details.SummaryDifference0.2%

- Check16 days agoChange DetectedThe page shows an updated revision label to v3.6.6, and several related topics entries (Melanoma, related topics:, MedlinePlus Genetics) as well as the previous revision marker (Revision: v3.6.5) were removed.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now lists 'Melanoma' and adds a 'related topics' section including 'MedlinePlus Genetics', enhancing topic tagging and linking to genetics resources.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page's revision tag was updated to v3.6.5 and the older v3.6.4 tag was removed. References to Melanoma and related topics, including MedlinePlus Genetics, were removed from the related topics section.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page revision was updated to v3.6.4, indicating a newer version of the page's documentation. The core study content and details remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.